Cargando…
Discovery of Dimeric Arylsulfonamides as Potent ADAM8 Inhibitors
[Image: see text] The metalloproteinase ADAM8 is upregulated in several cancers but has a dispensable function under physiological conditions. In tumor cells, ADAM8 is involved in invasion, migration, and angiogenesis. The use of bivalent inhibitors could impair migration and invasion through the do...
Autores principales: | Cuffaro, Doretta, Camodeca, Caterina, Tuccinardi, Tiziano, Ciccone, Lidia, Bartsch, Jörg W., Kellermann, Tanja, Cook, Lena, Nuti, Elisa, Rossello, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805605/ https://www.ncbi.nlm.nih.gov/pubmed/35111280 http://dx.doi.org/10.1021/acsmedchemlett.1c00411 |
Ejemplares similares
-
Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide
por: Santamaria, Salvatore, et al.
Publicado: (2021) -
Targeting Aggrecanases
for Osteoarthritis Therapy:
From Zinc Chelation to Exosite Inhibition
por: Cuffaro, Doretta, et al.
Publicado: (2022) -
Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
por: Calligaris, Matteo, et al.
Publicado: (2021) -
An overview of carbohydrate-based carbonic anhydrase inhibitors
por: Cuffaro, Doretta, et al.
Publicado: (2020) -
New isoxazolidinyl-based N-alkylethanolamines as new activators of human brain carbonic anhydrases
por: Cuffaro, Doretta, et al.
Publicado: (2023)